Jump Financial’s Oruka Therapeutics ORKA Stock Holding History

Jump Financial’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000	Closed	-$48K	–	1354
2020 Q4	$48K	Buy	+1,000	New	+$49.8K	0.01%	906

Other funds holding ORKA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

Jump Financial's ORKA Position: Q1 2021 in Review

Jump Financial sold out of Oruka Therapeutics (ORKA) in Q1 2021, closing a stake of 1,000 shares — an estimated $48K sold.

Jump Financial first reported a position in ORKA in Q4 2020 and held it in 1 quarter. The position peaked at $48K in Q4 2020. 17 funds tracked by Wall St. Rank hold ORKA as of Q1 2021.

Jump Financial reported no remaining Oruka Therapeutics position as of Q1 2021 after selling out during the quarter.
Jump Financial sold 1,000 Oruka Therapeutics shares in Q1 2021, an estimated $48K.
Jump Financial first reported a position in Oruka Therapeutics in Q4 2020 and held it in 1 quarter.
Jump Financial's Oruka Therapeutics position peaked at $48K in Q4 2020.
17 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2021.

Based on Jump Financial's 13F filing for Q1 2021, filed 17 May 2021.